Prevention and Treatment of Sepsis - Present and Future Problems

  • A. E. Baue
Conference paper


What is wrong is that we have become lumpers — lumping together various human illnesses and injuries and attempting to treat them based upon certain general symptoms (SIRS, for example). This approach has not worked nor will it. What is right is that we are beginning to recognize this and we are becoming splitters. The evolution of Roger Bones thinking about this is worth reviewing. Early on he was excited about SIRS and MODS and developed concepts of CARS, MARS, and CHAOS [1]. As more and more magic bullets failed, he progressively stressed the need to break down into separate units the problems you deal with within an ICU. From a lumper he was becoming a splitter. The day is over, or should be, when we attempt to treat a group of symptoms or signs which simply indicate that the patient is sick. This approach does not work.


Migration Inhibitory Factor Adult Respiratory Distress Syndrome Cecal Ligation Magic Bullet Diethyl Maleate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bone RC (1996) Sir Isaac Newton, sepsis, SIRS and CARS. Crit Care Med 24:1125–1138PubMedCrossRefGoogle Scholar
  2. 2.
    Baue AE (1997) Multiple Organ Failure, Multiple Organ Dysfunction Syndrome and Systemic Inflammatory Response Syndrome — Why no magic bullets? Arch Surg 132:703–707PubMedCrossRefGoogle Scholar
  3. 3.
    Skolnick AA (1997) Biological response modifiers may yield a new class of drugs to treat arthritis. JAMA 277:276–278PubMedCrossRefGoogle Scholar
  4. 4.
    Stehben WE (1993) Causality in medical science with particular reference to heart disease and arteriosclerosis. Persp Biol Med 36:97–119Google Scholar
  5. 5.
    Baue AE (1983) Shock research and therapy in the 1980’s. Keynote address. In: SM Reichard and RR Wolfe (eds). Advances in Shock Research 4:1–16Google Scholar
  6. 6.
    Mazumdar PMH ( 1995) Species and specificity: an interpretation of the history of immunology. Science xiv:457, Cambridge University Press, New YorkGoogle Scholar
  7. 7.
    Lesch JE (1996) Immunology dichotomized. 273:75–76Google Scholar
  8. 8.
    Bone RL (1996) Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 24:163–172PubMedCrossRefGoogle Scholar
  9. 9.
    Baue AE (1992) The horror autotoxicus and multiple organ failure. Arch Surg 127:1451–1462PubMedCrossRefGoogle Scholar
  10. 10.
    Tompkins RG (1997) The role of proinflammatory cytokines in inflammatory and metabolic responses. Ann Surg 225(3):243–245PubMedCrossRefGoogle Scholar
  11. 11.
    Roumen MH, Redl H, Schlag G et al (1995) Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 23(3):474–480PubMedCrossRefGoogle Scholar
  12. 12.
    Remick D, Manohar P, Bolgos G et al (1995) Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 2(2):89–95CrossRefGoogle Scholar
  13. 13.
    Riché F, Panis Y, Laisné M-J et al (1996) High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: A prospective study in 59 patients. Surgery 120(5):801–807PubMedCrossRefGoogle Scholar
  14. 14.
    Castelli MP, Black PL, Schneider M et al (1988) Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. J Immunol 140:3830PubMedGoogle Scholar
  15. 15.
    Cannon JG, Friedberg JS, Gelfand JA et al (1992) Circulating interleukin-1ß and tumor necrosis factor-α concentrations after burn injury in humans. Crit Care Med 20(10): 1414–1419PubMedCrossRefGoogle Scholar
  16. 16.
    O’Reilly M, Silver GM, Davis JH et al (1992) Interleukin Iß improves survival following cecal ligation and puncture. J Surg Res 52:518–522PubMedCrossRefGoogle Scholar
  17. 17.
    Moscovitz H, Shofer F, Mignott H (1994) Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 22(7): 1102–1107PubMedCrossRefGoogle Scholar
  18. 18.
    Kim JH, Jun TG, Sher TG (1995) Giant lymph node hyperplasia (Castelman’s disease) in the chest. Ann Thorac Surg 59:1162–1165PubMedCrossRefGoogle Scholar
  19. 19.
    Lange JR, Alexander HR, Merino M J et al (1992) Interleukin-1 a prevention of the lethality of Escherichia Coli peritonitis. J Surg Res 52:555–559PubMedCrossRefGoogle Scholar
  20. 20.
    León P, Redmond HP, Shou J et al (1992) Interleukin 1 and its relationship to endotoxin tolerance. Arch Surg 127:146–151PubMedCrossRefGoogle Scholar
  21. 21.
    Luger A, Graf H, Schwarz H-P et al (1986) Decreased serum interleukin 1 activity and monocyte interleukin 1 production in patients with fatal sepsis. Crit Care Med 14(5):458–461PubMedCrossRefGoogle Scholar
  22. 22.
    Echtenacher B, Männel DN, Hültner L (1996) Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75–77PubMedCrossRefGoogle Scholar
  23. 23.
    van der Poll T, Marchant A, Buurman WA et al (1995) Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 155:5397–5401PubMedGoogle Scholar
  24. 24.
    Greenberger MJ, Strieter RM, Kunkel SL et al (1995) Neutralization of IL-10 increases survival in a murine model of klebsiella pneumonia. J Immunol 155:722–729PubMedGoogle Scholar
  25. 25.
    Christou N, Meakins J, Gordon J et al (1995) The delayed hypersensitivity response and host resistance in surgical patients 20 years later. Ann Surg 222(4):534–548PubMedGoogle Scholar
  26. 26.
    Baue AE (1996) Prologue — The concept of limits and emergence of MOE In: Faist E, Baue AE, Schildberg FW (eds) The immune consequences of trauma, shock and sepsis. Pabst Science Publishers, Berlin Germany, II-1:20–31Google Scholar

Copyright information

© Springer-Verlag Italia, Milano 1999

Authors and Affiliations

  • A. E. Baue

There are no affiliations available

Personalised recommendations